T1	Encounter 25 36	Outpatients
E1	Encounter:T1
T2	Modifier 57 67	Cardiology
E2	Modifier:T2
T3	Modifier 69 82	Endocrinology
E3	Modifier:T3
T4	Modifier 84 94	Nephrology
E4	Modifier:T4
T5	Modifier 96 105	Neurology
E5	Modifier:T5
T6	Modifier 107 117	Geriatrics
E6	Modifier:T6
T7	Or 118 120	or
E7	Or:T7
T8	Modifier 121 128	General
E8	Modifier:T8
T9	Procedure 129 146	Internal Medicine
E9	Procedure:T9
T10	Condition 166 178	hypertension
E10	Condition:T10 Name:T56
T11	Observation 214 216	BP
E11	Observation:T11 Name:T57
T12	Temporal-Connection 226 236	at the day
E12	Temporal-Connection:T12
A1	Temporal-Connection-Type-Value E12 during
T13	Encounter 240 245	visit
E13	Encounter:T13
T14	And 246 249	and
E14	And:T14
T15	Eq-Comparison 250 267	at least one time
E15	Eq-Comparison:T15 Operator:T59 Value:T60 Temporal-Unit:T61
T16	Temporal-Connection 268 274	before
E16	Temporal-Connection:T16
A2	Temporal-Connection-Type-Value E16 before
T17	Modifier 299 313	cut-off values
E17	Modifier:T17
T18	Eq-Comparison 316 329	≥140 mmHg SBP
E18	Eq-Comparison:T18 Value:T63 Unit:T64 Unit:T65
T19	Or 330 336	and/or
E19	Or:T19
T20	Eq-Comparison 337 349	≥90 mmHg DBP
E20	Eq-Comparison:T20 Value:T66 Unit:T67 Unit:T68
T21	Eq-Comparison 379 381	BP
E21	Eq-Comparison:T21
T22	Temporal-Connection 382 392	at the day
E22	Temporal-Connection:T22
A3	Temporal-Connection-Type-Value E22 during
T23	Encounter 396 401	visit
E23	Encounter:T23
T24	Temporal-Connection 439 442	pre
E24	Temporal-Connection:T24
A4	Temporal-Connection-Type-Value E24 before
T25	Procedure 443 452	treatment
E25	Procedure:T25
T26	Drug 458 480	antihypertensive drugs
E26	Drug:T26 Name:T73
T27	Eq-Comparison 481 490	≥ 2 weeks
E27	Eq-Comparison:T27 Operator:T74 Value:T75 Temporal-Unit:T76
T28	Age 556 560	aged
E28	Age:T28
T29	Eq-Comparison 560 570	< 18 years
E29	Eq-Comparison:T29 Operator:T77 Value:T78 Temporal-Unit:T79
T30	Negation 590 597	without
E30	Negation:T30
T31	Condition 622 638	hypertension（for
E31	Condition:T31 Name:T80
T32	Eq-Comparison 673 679	taking
E32	Eq-Comparison:T32 Temporal-Period:T81
T33	Drug 680 702	antihypertensive drugs
E33	Drug:T33 Name:T82
T34	Assertion 722 734	difficult to
E34	Assertion:T34
A5	Assertion-Type-Value E34 hypothetical
T35	Condition 760 772	hypertension
E35	Condition:T35 Name:T83
T36	Condition 818 840	secondary hypertension
E36	Condition:T36 Name:T84
T37	Condition 870 882	dyslipidemia
E37	Condition:T37 Name:T85
T38	And 883 887	with
E38	And:T38
T39	Condition 888 899	clear cause
E39	Condition:T39 Name:T86
T40	Condition 909 927	nephrotic syndrome
E40	Condition:T40 Name:T87
T41	Condition 936 950	hypothyroidism
E41	Condition:T41 Name:T89
T42	Condition 952 980	terminal stage of malignancy
E42	Condition:T42 Name:T90
T43	Modifier 1015 1024	end-stage
E43	Modifier:T43
T44	Condition 1025 1038	renal disease
E44	Condition:T44
T45	Procedure 1040 1052	hemodialysis
E45	Procedure:T45 Name:T92
T46	Or 1054 1057	and
E46	Or:T46
T47	Procedure 1058 1077	peritoneal dialysis
E47	Procedure:T47 Name:T93
T48	Condition 1117 1137	mental abnormalities
E48	Condition:T48 Name:T94
T49	And 1138 1141	who
E49	And:T49
T50	Negation 1146 1152	unable
E50	Negation:T50
T51	Observation 1169 1182	questionnaire
E51	Observation:T51
T52	Study 1229 1237	research
E52	Study:T52
T53	Temporal-Connection 1238 1244	during
E53	Temporal-Connection:T53
A6	Temporal-Connection-Type-Value E53 during
T54	Study 1250 1255	study
E54	Study:T54
T55	Encounter-Type 25 36	Outpatients
A7	Encounter-Type-Value T55 inpatient
T56	Condition-Name 166 178	hypertension
T57	Observation-Name 214 216	BP
A8	Observation-Type-Value T57 vital
T58	Eq-Temporal-Unit 233 236	day
A9	Eq-Temporal-Unit-Value T58 day
T59	Eq-Operator 250 258	at least
A10	Eq-Operator-Value T59 GTEQ
T60	Eq-Value 259 262	one
T61	Eq-Temporal-Unit 263 267	time
A11	Eq-Temporal-Unit-Value T61 minute
T62	Eq-Temporal-Unit 280 283	day
A12	Eq-Temporal-Unit-Value T62 day
T63	Eq-Value 316 320	≥140
T64	Eq-Unit 321 325	mmHg
T65	Eq-Unit 326 329	SBP
T66	Eq-Value 337 340	≥90
T67	Eq-Unit 341 345	mmHg
T68	Eq-Unit 346 349	DBP
T69	Condition-Name 352 357	2)for
T70	Polarity 372 378	normal
A13	Polarity-Value T70 normal
T71	Observation-Name 379 381	BP
T72	Eq-Temporal-Period 433 442	given pre
A14	Eq-Temporal-Period-Value T72 past
T73	Drug-Name 458 480	antihypertensive drugs
T74	Eq-Operator 481 482	≥
A15	Eq-Operator-Value T74 GTEQ
T75	Eq-Value 483 484	2
T76	Eq-Temporal-Unit 485 490	weeks
A16	Eq-Temporal-Unit-Value T76 week
T77	Eq-Operator 560 561	<
A17	Eq-Operator-Value T77 LT
T78	Eq-Value 562 564	18
T79	Eq-Temporal-Unit 565 570	years
A18	Eq-Temporal-Unit-Value T79 year
T80	Condition-Name 622 638	hypertension（for
T81	Eq-Temporal-Period 673 679	taking
A19	Eq-Temporal-Period-Value T81 present
T82	Drug-Name 680 702	antihypertensive drugs
T83	Condition-Name 760 772	hypertension
T84	Condition-Name 818 840	secondary hypertension
T85	Condition-Name 870 882	dyslipidemia
T86	Condition-Name 888 899	clear cause
T87	Condition-Name 909 927	nephrotic syndrome
T88	Severity 929 935	severe
A20	Severity-Value T88 severe
T89	Condition-Name 936 950	hypothyroidism
T90	Condition-Name 970 980	malignancy
T91	Condition-Name 1019 1038	stage renal disease
T92	Procedure-Name 1040 1052	hemodialysis
T93	Procedure-Name 1058 1077	peritoneal dialysis
T94	Condition-Name 1117 1137	mental abnormalities